Olympus Corporation

Here's the thing about Olympus that most people don't realize anymore-it's not the camera company you might remember. Not since 2021, anyway. The brand that once sat in your hands as a compact digital camera or an OM-series film body has completely transformed into something else entirely: a pure-play medical technology giant.

And honestly? That transformation makes sense when you look at the numbers. Olympus holds roughly a 70 percent share of the global endoscope market, estimated to be worth approximately US$2.5 billion. That's not just market leadership-that's dominance. While you were snapping photos with their cameras, Olympus was quietly becoming the go-to name in gastrointestinal endoscopy, surgical energy devices, and minimally invasive medical procedures.

The company's been around since 1919, starting with microscopes and thermometers. But the pivot to medical tech wasn't some recent panic move-it's been their bread and butter for decades. They pioneered the world's first gastrocamera, the first waterproof bronchoscope, and the first endoscope system with high-definition imaging. These aren't just incremental improvements; they're the kind of innovations that change how doctors diagnose and treat cancer, respiratory diseases, and dozens of other conditions.

So what happened to those cameras? Since January 2021 these products have been transferred to and are being marketed, sold and distributed by OM Digital Solutions. Same goes for the microscopes and industrial equipment-spun off to a company called Evident in 2023. Olympus made a calculated decision: focus entirely on medical systems where they're already the global leader.

Olympus Corporation of the Americas, a wholly owned subsidiary of Olympus Corporation, is headquartered in Center Valley, Pennsylvania, USA, and employs more than 4,500 employees throughout locations in North and South America. They've got manufacturing facilities in Minnesota for surgical energy products, R&D centers in Tennessee for ENT devices, and distribution networks spanning the hemisphere. This isn't a scrappy startup-it's a well-oiled machine with over 31,000 employees worldwide.

The company's purpose statement feels almost understated: "Making people's lives healthier, safer and more fulfilling." But when you're producing the endoscopes that detect early-stage colon cancer or the surgical tools that enable minimally invasive procedures, that's not marketing fluff. That's literally what they do every day.

One more thing worth noting-Olympus weathered one of Japan's biggest corporate scandals back in 2011, involving billions in hidden losses and a whistleblowing CEO. They paid $646 million in fines, cleaned house, and kept moving forward. The fact that they emerged from that mess and doubled down on medical tech shows serious institutional resilience.

So yeah, if you're looking for the Olympus that made your old E-M5 camera, that's OM System now. But if you're a healthcare professional or someone interested in medical technology innovation, this Olympus-the one that's been quietly revolutionizing how doctors see inside the human body for decades-is the one that matters.